A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients (Q57570360)
Jump to navigation
Jump to search
article by Lorenzo Pilla et al published 8 October 2005 in Cancer Immunology, Immunotherapy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients |
article by Lorenzo Pilla et al published 8 October 2005 in Cancer Immunology, Immunotherapy |
Statements
A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients (English)
0 references
8 October 2005
0 references
55
0 references
8
0 references
958-968
0 references
1 reference